Chinese firms including network equipment vendor Huawei Technologies Co. and drone maker SZ DJI Technology Co. topped 381 that were found falsifying records to receive South Korea's country's communications equipment certification.
According to the Ministry of Science and ICT, the falsified test records pertain to 1,700 communications equipment.
Closed-circuit TV camera manufacturer Hangzhou HIKVISION Digital Tech Co. had the most falsified records with 224 pieces of equipment, followed by DJI at 145, and Huawei at 136.
South Korea's Samsung Electronics Co. was 10th with 23 false records on equipment, including wireless speakers.
The ICT ministry, which investigated equipment that gained certification beginning in 2006, announced that the National Radio Research Agency will begin a hearing on the 381 falsifying companies next month.
Under South Korea's local radio wave law, falsifying records on equipment certification could result in cancellation and withdrawal of the equipment involved.


Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



